GMVAX
Price
$19.08
Change
-$0.18 (-0.93%)
Updated
Jul 13 closing price
Net Assets
152.73M
VIMSX
Price
$88.29
Change
-$0.11 (-0.12%)
Updated
Jul 13 closing price
Net Assets
223.97B
Interact to see
Advertisement

GMVAX vs VIMSX

GMVAX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
GMVAX vs. VIMSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVAX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 224B vs. GMVAX (153M). VIMSX pays higher dividends than GMVAX: VIMSX (1.20) vs GMVAX (0.00). GMVAX was incepted earlier than VIMSX: GMVAX (12 years) vs VIMSX (28 years). GMVAX (1.45) is less costly to investors than VIMSX (0.17). GMVAX is a more actively managed with annual turnover of: 100.00 vs. VIMSX (16.00). GMVAX has a lower initial minimum investment than VIMSX: GMVAX (1000) vs VIMSX (3000). GMVAX annual gain was more profitable for investors over the last year : 17.73 vs. VIMSX (14.84). VIMSX return over 5 years is better than : 38.66 vs. GMVAX (19.07).
GMVAXVIMSXGMVAX / VIMSX
Total Expense Ratio1.170.17688%
Annual Report Gross Expense Ratio1.450.17853%
Fund Existence12 years28 years-
Gain YTD18.08711.650155%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets153M224B0%
Annual Yield % from dividends0.001.20-
Returns for 1 year17.7314.84119%
Returns for 3 years33.7644.7575%
Returns for 5 years19.0738.6649%
Returns for 10 years83.44158.3753%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUETX42.69N/A
N/A
MFS Blended Research Core Equity R3
NRSRX65.08N/A
N/A
Neuberger Quality Equity R6
CRIHX13.98N/A
N/A
CRM Long/Short Opportunities Instl
LFLTX16.45N/A
N/A
Lord Abbett Focused Large Cap Value R5
ANWFX74.06-0.99
-1.32%
American Funds New Perspective F-2